Artal Participations S.a r.l. — SEC Form 4 filings
SEC reporting owner CIK 2048403. 4 Form 4 filings on record with FilingPulse; latest filed 2026-06-17.
Transaction summary — filings shown
Covers all 4 filings on record, filed 2026-02-04 to 2026-06-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 1,538,462 shares, $2,000,001 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 3,000,000 shares, $270,900,000 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 3,000,000 shares @ $90.30 ($270,900,000) in CAVA GROUP, INC., filed 2026-06-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CAVA GROUP, INC. (CAVA) | Director | 1 | — | 1 leg · 3,000,000 sh · $270,900,000 | — |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | Director, 10% owner | 3 | 1 leg · 1,538,462 sh · $2,000,001 | — | 7 |
Form 4 filings — Artal Participations S.a r.l.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-17 | 4 | CAVA GROUP, INC. (CAVA) jointly with Artal International S.C.A., Artal International Management S.A., Artal Group S.A., Westend S.A., Stichting Administratiekantoor Westend, Wittouck Amaury | Sale (S): 3,000,000 @ $90.30 | EDGAR |
| 2026-05-08 | 4 | LEXICON PHARMACEUTICALS, INC. (LXRX) jointly with Artal International S.C.A., Artal International Management S.A., Artal Group S.A., Westend S.A., Stichting Administratiekantoor Westend, Wittouck Amaury | Option exercise (M): 20,421,735 @ $0 · Grant/award (A): 408,434.70 (derivative) · Option exercise (M): 408,434.70 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | LEXICON PHARMACEUTICALS, INC. (LXRX) jointly with Artal International S.C.A., Artal International Management S.A., Artal Group S.A., Westend S.A., Stichting Administratiekantoor Westend, Wittouck Amaury | Grant/award (A): 41,289.58 @ $65 | EDGAR |
| 2026-02-04 | 4 | LEXICON PHARMACEUTICALS, INC. (LXRX) jointly with Invus Global Management, LLC, Siren, L.L.C., DEBBANE RAYMOND, Artal International S.C.A., Artal International Management S.A., Artal Group S.A., Westend S.A., Stichting Administratiekantoor Westend | Grant/award (A): 18,553,846 @ $1.30 · Grant/award (A): 3,846,154 @ $1.30 · Purchase (P): 1,538,462 @ $1.30 · Grant/award (A): 367,145.12 @ $65 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2048403 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →